BackCelyad Oncology Overview

Celyad Oncology Other Income Expense Net

Other Income/Expense Net for CYAD.

Quarterly Other Income/Expense

-$5000.00
↑ 91.53% YoY

As of Dec 31, 2024

Annual Other Income/Expense (TTM)

$1.92M
↑ 19080% YoY

Trailing 12 months ending Dec 31, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin